OpenAI Expands GPT-Rosalind Globally, Lifting LabWorkBench Score to 63.2%
Updated
Updated · OpenAI · Jun 3
OpenAI Expands GPT-Rosalind Globally, Lifting LabWorkBench Score to 63.2%
3 articles · Updated · OpenAI · Jun 3
Summary
GPT-Rosalind is now in research preview for eligible organizations worldwide, with OpenAI positioning the updated model for enterprise-scale drug discovery, genomics and wet-lab research.
63.2% on LabWorkBench versus 55.8% for GPT-5.5 marked the biggest disclosed gain, while the model also scored 27.5% versus 25.1% on MedChemBench and 21.6% versus 20.4% on GeneBench.
31% fewer tokens on GeneBench, 7.2% fewer on MedChemBench and 5.3% fewer on LabWorkBench suggest OpenAI is pairing higher accuracy with lower compute use in long-horizon scientific workflows.
Codex now offers Life Sciences Research and NGS Analysis plugins plus sequence, alignment and structure viewers, giving researchers a workspace for evidence retrieval, bioinformatics execution and provenance tracking.
Novo Nordisk is among the first named users under OpenAI's trusted-access model, which limits GPT-Rosalind to qualified organizations with governance, safety oversight and enterprise-grade security.
Can AI truly discover novel medicines, or will it just amplify hidden biases in scientific data?
When an AI helps invent a new life-saving drug, who legally owns the patent?
OpenAI’s GPT-Rosalind in 2026: Market Impact, Scientific Integration, and the Future of AI in Life Sciences
Overview
OpenAI's GPT-Rosalind is rapidly expanding worldwide, driven by its advanced capabilities that help organizations explore more possibilities, find hidden connections, and generate better hypotheses faster. This powerful AI model is designed to accelerate discovery and streamline research workflows, making it attractive to global enterprises in complex scientific fields. By leveraging GPT-Rosalind, organizations can unlock new efficiencies and foster innovation, optimizing their research processes and improving decision-making. OpenAI’s ongoing focus on these strengths positions GPT-Rosalind as a key tool for advancing scientific research and supporting strategic growth across industries.